On October 2, 2023 AskAt reported a Notice of Allowance for a Mexican patent dated September 15, 2023 from the National Institute of Indigenous Peoples (Instituto Nacional de los Pueblos Indígenas, INPI) for a salt and crystal forms patent for its CB2 agonist, AAT-730 (Press release, AskAt, OCT 2, 2023, View Source [SID1234635559]). The notice was issued in connection with Mexican Patent Application No. MX/a/2023/005430 (Filing Date: November 11, 2021). In addition to Mexico, AskAt has received a salt and crystal forms patent in Australia.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!